Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance upgrade on Thursday 4th of May 2017 from 8.00am to 9.00am (BST).

During this time our websites will be offline temporarily. If you have any questions please use the feedback button on this page. We apologise for any inconvenience this might cause and thank you for your patience.

Issue 10, 2015
Previous Article Next Article

Nanocarriers in therapy of infectious and inflammatory diseases

Author affiliations


Nanotechnology is a growing science that has applications in various areas of medicine. The composition of nanocarriers for drug delivery is critical to guarantee high therapeutic performance when targeting specific host sites. Applications of nanotechnology are prevalent in the diagnosis and treatment of infectious and inflammatory diseases. This review summarizes recent advancements in the application of nanotechnology to the therapy of infectious and inflammatory diseases. The major focus is on the design and fabrication of various nanomaterials, characteristics and physicochemical properties of drug-loaded nanocarriers, and the use of these nanoscale drug delivery systems in treating infectious and inflammatory diseases, such as AIDS, hepatitis, tuberculosis, melanoma, and representative inflammatory diseases. Clinical trials and future perspective of the use of nanocarriers are also discussed in detail. We hope that such a review will be valuable to researchers who are exploring nanoscale drug delivery systems for the treatment of specific infectious and inflammatory diseases.

Graphical abstract: Nanocarriers in therapy of infectious and inflammatory diseases

Back to tab navigation
Please wait while Download options loads

Publication details

The article was received on 31 Dec 2014, accepted on 05 Feb 2015 and first published on 06 Feb 2015

Article type: Review Article
DOI: 10.1039/C4NR07682F
Citation: Nanoscale, 2015,7, 4291-4305
  •   Request permissions

    Nanocarriers in therapy of infectious and inflammatory diseases

    U. Ikoba, H. Peng, H. Li, C. Miller, C. Yu and Q. Wang, Nanoscale, 2015, 7, 4291
    DOI: 10.1039/C4NR07682F

Search articles by author